Finch and Takeda to jointly develop microbiome therapeutics in IBD

This article was originally published here

Microbiome engineering company, Finch Therapeutics and Takeda Pharmaceutical have reached a global collaboration agreement for the joint development of FIN-524.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply